ALAMEDA, Calif., April 23 /PRNewswire-FirstCall/ -. Avigen, Inc. , a biopharmaceutical company innovating therapeutics for neurological care, will hold its quarterly conference call to discuss first quarter results on Wednesday, April 30, 2008, at 1:00 p.m. ET (10:00 a.m. PT). Kenneth Chahine, Chief Executive Officer, and Michael Coffee, Chief Business Officer, can be heard by calling 888-713-4217 (U.S.) or 617-213-4869 (non-U.S. locations) using passcode 94095794.
This call is being webcast by Thomson/CCBN and can be accessed at Avigen's website at http://www.avigen.com. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.
A rebroadcast of the call will be available shortly after the conclusion of the session. The replay may be accessed over the Internet at http://www.avigen.com or by calling 888-286-8010 (U.S.) or 617-801-6888 (non-U.S. locations) using passcode 84391015.
About Avigen
Avigen is a biopharmaceutical company focused on developing and commercializing small molecule therapeutics to treat serious neurological disorders, including neuropathic pain and neuromuscular spasm and spasticity. For press releases and other corporate information, visit our website at http://www.avigen.com.
CONTACT: Michael Coffee, Chief Business Officer of Avigen, Inc.,
+1-510-748-7372, ir@avigen.com
Web site: http://www.avigen.com/
http://www.streetevents.com/
http://www.earnings.com/
